New York Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation), By End Use, And Segment Forecasts, 2026 - 2033
The New York legal cannabis market size was estimated at USD 2.52 billion in 2025 and is expected to reach USD 6.06 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market growth is driven by the legalization of cannabis, increasing awareness regarding the therapeutic benefits of cannabis-based products, and the rising use of cannabis for both medical and recreational purposes.
For instance, in January 2026, the state witnessed rapid retail expansion, with the number of licensed cannabis retailers increasing to 556 by the end of 2025, up from 261 in 2024, with more than 200 stores concentrated in New York City, reflecting strong market penetration and improving legal access.
New York Legal Cannabis Market Report Segmentation
This report forecasts revenue growth and provides at country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the New York legal cannabis market report based on source, derivatives, cultivation, and end use:
For instance, in January 2026, the state witnessed rapid retail expansion, with the number of licensed cannabis retailers increasing to 556 by the end of 2025, up from 261 in 2024, with more than 200 stores concentrated in New York City, reflecting strong market penetration and improving legal access.
New York Legal Cannabis Market Report Segmentation
This report forecasts revenue growth and provides at country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the New York legal cannabis market report based on source, derivatives, cultivation, and end use:
- Source Outlook (Revenue, USD Million, 2021 - 2033)
- Hemp
- Hemp Oil
- Industrial Hemp
- Marijuana
- Flower
- Oil and Tinctures
- Derivatives Outlook (Revenue, USD Million, 2021 - 2033)
- CBD
- THC
- Others
- Cultivation Outlook (Revenue, USD Million, 2021 - 2033)
- Indoor Cultivation
- Greenhouse Cultivation
- Outdoor Cultivation
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Industrial Use
- Medical Use
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Post Traumatic Stress Disorder (PTSD)
- Cancer
- Migraines
- Epilepsy
- Alzheimer’s
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Tourette’s
- Diabetes
- Parkinson's
- Glaucoma
- Others
- Recreational Use
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Estimates and Forecast Timeline
1.3. Objectives
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.5.5. Details of Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Data Validation & Publishing
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Abbreviations
1.11. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, AND SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. New York Legal Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing adoption of cannabis for treatment of chronic diseases
3.2.1.2. Growing demand for cannabis-based CBD products
3.2.1.3. Structured regulatory framework and supportive reimbursement policies market
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of cannabis and CBD-based products
3.2.2.2. Lack of consistency in advertising policies regarding cannabis
3.3. Business Environment Analysis Tools: New York Legal Cannabis Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Regulatory Scenario
3.4.1. Overview
3.4.2. Regulatory Bodies Involved in New York
3.4.3. Licensing Scenario in New York, by counties
3.4.4. Risk and Opportunities Related to Regulations in the New York
3.4.5. Legal Status
3.4.6. Cultivation/Production Norms
3.4.7. Regulatory Hurdles for Market Entry
3.4.8. Distribution, Retail Compliance, And Marketing/Advertising Guidelines
3.5. Jurisdiction
3.6. New York Legal Cannabis Market: Risk Exposure, Insurance Penetration, and Reinsurance Outlook
3.6.1. Risk & Exposure Analysis for Insurers
3.6.2. Loss Trends & Claim Experience
3.6.3. Insurance Penetration & Coverage Opportunities
3.6.4. Reinsurance Market Perspective & Capital Flows
3.6.5. Emerging Coverage Areas & Product Innovations
3.7. Legal Cannabis Seed to Shelf Story
3.8. Supply Chain Analysis
3.9. Guidelines and Requirements for Cannabis Cultivation
3.10. Government Policy Designing Cannabis Guidelines
3.10.1. Federal Cannabis Policy
3.10.2. Policy Challenges and Opportunities
3.11. Reimbursement Policies in New York
3.12. Taxation Policies in New York
CHAPTER 4. NEW YORK LEGAL CANNABIS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1. Segment Definitions
4.2. Segment Dashboard
4.3. New York Legal Cannabis Market: Source Movement & Market Share Analysis, 2025 & 2033
4.4. New York Legal Cannabis Market Size & Trend Analysis, by Source, 2021 - 2033 (USD Million)
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. NEW YORK LEGAL CANNABIS MARKET: DERIVATIVE ESTIMATES & TREND ANALYSIS
5.1. Segment Definitions
5.2. Segment Dashboard
5.3. New York Legal Cannabis Market: Derivative Movement & Market Share Analysis, 2025 & 2033
5.4. New York Legal Cannabis Market Size & Trend Analysis, by Derivative, 2021 - 2033 (USD Million)
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. NEW YORK LEGAL CANNABIS MARKET: CULTIVATION ESTIMATES & TREND ANALYSIS
6.1. Segment Definitions
6.2. Segment Dashboard
6.3. New York Legal Cannabis Market: Cultivation Movement & Market Share Analysis, 2025 & 2033
6.4. New York Legal Cannabis Market Size & Trend Analysis, by Cultivation, 2021 - 2033 (USD Million)
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. NEW YORK LEGAL CANNABIS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Definitions
7.2. Segment Dashboard
7.3. New York Legal Cannabis Market: End Use Movement & Market Share Analysis, 2025 & 2033
7.4. New York Legal Cannabis Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
7.5. Medical Use
7.5.1. Medical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Cancer
7.5.2.1. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Chronic Pain
7.5.3.1. Chronic Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. Depression and Anxiety
7.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Arthritis
7.5.5.1. Arthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Diabetes
7.5.6.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Glaucoma
7.5.7.1. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Migraines
7.5.8.1. Migraines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Epilepsy
7.5.9.1. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.11. AIDS
7.5.11.1. AIDS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis
7.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.13. Alzheimers's
7.5.13.1. Alzheimers's Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.15. Parkinson's
7.5.15.1. Parkinson's Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.16. Tourettes
7.5.16.1. Tourettes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.17. Others
7.5.17.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 8. NEW YORK LEGAL CANNABIS MARKET: COMPETITIVE LANDSCAPE
8.1. Participant’s Categorization
8.2. Company Market Position Analysis, 2025
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. Curaleaf Holdings, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. New York Hemp Oil
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. ACREAGE HOLDINGS.
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Cannabist Company Holdings Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Cresco Labs.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. PharmaCann Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Vireo Health International, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Green Thumb Industries (GTI)
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Tilray Brands, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Estimates and Forecast Timeline
1.3. Objectives
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.5.5. Details of Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Data Validation & Publishing
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Abbreviations
1.11. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, AND SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. New York Legal Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing adoption of cannabis for treatment of chronic diseases
3.2.1.2. Growing demand for cannabis-based CBD products
3.2.1.3. Structured regulatory framework and supportive reimbursement policies market
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of cannabis and CBD-based products
3.2.2.2. Lack of consistency in advertising policies regarding cannabis
3.3. Business Environment Analysis Tools: New York Legal Cannabis Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Regulatory Scenario
3.4.1. Overview
3.4.2. Regulatory Bodies Involved in New York
3.4.3. Licensing Scenario in New York, by counties
3.4.4. Risk and Opportunities Related to Regulations in the New York
3.4.5. Legal Status
3.4.6. Cultivation/Production Norms
3.4.7. Regulatory Hurdles for Market Entry
3.4.8. Distribution, Retail Compliance, And Marketing/Advertising Guidelines
3.5. Jurisdiction
3.6. New York Legal Cannabis Market: Risk Exposure, Insurance Penetration, and Reinsurance Outlook
3.6.1. Risk & Exposure Analysis for Insurers
3.6.2. Loss Trends & Claim Experience
3.6.3. Insurance Penetration & Coverage Opportunities
3.6.4. Reinsurance Market Perspective & Capital Flows
3.6.5. Emerging Coverage Areas & Product Innovations
3.7. Legal Cannabis Seed to Shelf Story
3.8. Supply Chain Analysis
3.9. Guidelines and Requirements for Cannabis Cultivation
3.10. Government Policy Designing Cannabis Guidelines
3.10.1. Federal Cannabis Policy
3.10.2. Policy Challenges and Opportunities
3.11. Reimbursement Policies in New York
3.12. Taxation Policies in New York
CHAPTER 4. NEW YORK LEGAL CANNABIS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1. Segment Definitions
4.2. Segment Dashboard
4.3. New York Legal Cannabis Market: Source Movement & Market Share Analysis, 2025 & 2033
4.4. New York Legal Cannabis Market Size & Trend Analysis, by Source, 2021 - 2033 (USD Million)
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. NEW YORK LEGAL CANNABIS MARKET: DERIVATIVE ESTIMATES & TREND ANALYSIS
5.1. Segment Definitions
5.2. Segment Dashboard
5.3. New York Legal Cannabis Market: Derivative Movement & Market Share Analysis, 2025 & 2033
5.4. New York Legal Cannabis Market Size & Trend Analysis, by Derivative, 2021 - 2033 (USD Million)
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. NEW YORK LEGAL CANNABIS MARKET: CULTIVATION ESTIMATES & TREND ANALYSIS
6.1. Segment Definitions
6.2. Segment Dashboard
6.3. New York Legal Cannabis Market: Cultivation Movement & Market Share Analysis, 2025 & 2033
6.4. New York Legal Cannabis Market Size & Trend Analysis, by Cultivation, 2021 - 2033 (USD Million)
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. NEW YORK LEGAL CANNABIS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Definitions
7.2. Segment Dashboard
7.3. New York Legal Cannabis Market: End Use Movement & Market Share Analysis, 2025 & 2033
7.4. New York Legal Cannabis Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
7.5. Medical Use
7.5.1. Medical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Cancer
7.5.2.1. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Chronic Pain
7.5.3.1. Chronic Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. Depression and Anxiety
7.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Arthritis
7.5.5.1. Arthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Diabetes
7.5.6.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Glaucoma
7.5.7.1. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Migraines
7.5.8.1. Migraines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Epilepsy
7.5.9.1. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.11. AIDS
7.5.11.1. AIDS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis
7.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.13. Alzheimers's
7.5.13.1. Alzheimers's Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.15. Parkinson's
7.5.15.1. Parkinson's Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.16. Tourettes
7.5.16.1. Tourettes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.17. Others
7.5.17.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 8. NEW YORK LEGAL CANNABIS MARKET: COMPETITIVE LANDSCAPE
8.1. Participant’s Categorization
8.2. Company Market Position Analysis, 2025
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. Curaleaf Holdings, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. New York Hemp Oil
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. ACREAGE HOLDINGS.
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Cannabist Company Holdings Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Cresco Labs.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. PharmaCann Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Vireo Health International, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Green Thumb Industries (GTI)
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Tilray Brands, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 New York legal cannabis market, by source, 2021 - 2033 (USD Million)
Table 4 New York legal cannabis market, by derivative, 2021 - 2033 (USD Million)
Table 5 New York legal cannabis market, by cultivation, 2021 - 2033 (USD Million)
Table 5 New York legal cannabis market, by end use, 2021 - 2033 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 New York legal cannabis market, by source, 2021 - 2033 (USD Million)
Table 4 New York legal cannabis market, by derivative, 2021 - 2033 (USD Million)
Table 5 New York legal cannabis market, by cultivation, 2021 - 2033 (USD Million)
Table 5 New York legal cannabis market, by end use, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 New York legal cannabis market: market outlook
Fig. 9 New York legal cannabis competitive insights
Fig. 9 History of medical and industrial use of cannabis in New York
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 New York legal cannabis market driver impact
Fig. 14 New York legal cannabis market restraint impact
Fig. 15 New York legal cannabis market: Source movement analysis
Fig. 16 New York legal cannabis market: Source outlook and key takeaways
Fig. 17 Marijuana market estimates and forecast, 2021 - 2033
Fig. 18 Flower market estimates and forecast, 2021 - 2033
Fig. 19 Oil and Tinctures market estimates and forecast, 2021 - 2033
Fig. 21 Hemp market estimates and forecast, 2021 - 2033
Fig. 22 Hemp CBD market estimates and forecast, 2021 - 2033
Fig. 23 Industrial Hemp market estimates and forecast, 2021 - 2033
Fig. 24 New York legal cannabis Market: Derivatives movement Analysis
Fig. 25 New York legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2021 - 2033
Fig. 27 THC market estimates and forecasts, 2021 - 2033
Fig. 28 Others market estimates and forecasts, 2021 - 2033
Fig. 29 New York legal cannabis Market: Cultivation movement Analysis
Fig. 30 New York legal cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2021 - 2033
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2021 - 2033
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2021 - 2033
Fig. 34 New York legal cannabis market: End Use movement analysis
Fig. 35 New York legal cannabis market: End Use outlook and key takeaways
Fig. 36 Medical use market estimates and forecasts, 2021 - 2033
Fig. 37 Cancer market estimates and forecasts, 2021 - 2033
Fig. 38 Chronic Pain market estimates and forecasts, 2021 - 2033
Fig. 39 Depression and Anxiety market estimates and forecasts, 2021 - 2033
Fig. 40 Arthritis market estimates and forecasts, 2021 - 2033
Fig. 41 Diabetes market estimates and forecasts, 2021 - 2033
Fig. 42 Glaucoma market estimates and forecasts, 2021 - 2033
Fig. 43 Migraines market estimates and forecasts, 2021 - 2033
Fig. 44 Epilepsy market estimates and forecasts, 2021 - 2033
Fig. 45 Multiple Sclerosis market estimates and forecasts, 2021 - 2033
Fig. 46 AIDS market estimates and forecasts, 2021 - 2033
Fig. 47 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2021 - 2033
Fig. 48 Alzheimers's market estimates and forecasts, 2021 - 2033
Fig. 49 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2021 - 2033
Fig. 50 Parkinson's market estimates and forecasts, 2021 - 2033
Fig. 51 Tourettes market estimates and forecasts, 2021 - 2033
Fig. 52 Others market estimates and forecasts, 2021 - 2033
Fig. 53 Recreational use market estimates and forecasts, 2021 - 2033
Fig. 54 Industrial use market estimates and forecasts, 2021 - 2033
Fig. 55 Key company categorization
Fig. 56 Heat map analysis, 2025
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 New York legal cannabis market: market outlook
Fig. 9 New York legal cannabis competitive insights
Fig. 9 History of medical and industrial use of cannabis in New York
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 New York legal cannabis market driver impact
Fig. 14 New York legal cannabis market restraint impact
Fig. 15 New York legal cannabis market: Source movement analysis
Fig. 16 New York legal cannabis market: Source outlook and key takeaways
Fig. 17 Marijuana market estimates and forecast, 2021 - 2033
Fig. 18 Flower market estimates and forecast, 2021 - 2033
Fig. 19 Oil and Tinctures market estimates and forecast, 2021 - 2033
Fig. 21 Hemp market estimates and forecast, 2021 - 2033
Fig. 22 Hemp CBD market estimates and forecast, 2021 - 2033
Fig. 23 Industrial Hemp market estimates and forecast, 2021 - 2033
Fig. 24 New York legal cannabis Market: Derivatives movement Analysis
Fig. 25 New York legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2021 - 2033
Fig. 27 THC market estimates and forecasts, 2021 - 2033
Fig. 28 Others market estimates and forecasts, 2021 - 2033
Fig. 29 New York legal cannabis Market: Cultivation movement Analysis
Fig. 30 New York legal cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2021 - 2033
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2021 - 2033
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2021 - 2033
Fig. 34 New York legal cannabis market: End Use movement analysis
Fig. 35 New York legal cannabis market: End Use outlook and key takeaways
Fig. 36 Medical use market estimates and forecasts, 2021 - 2033
Fig. 37 Cancer market estimates and forecasts, 2021 - 2033
Fig. 38 Chronic Pain market estimates and forecasts, 2021 - 2033
Fig. 39 Depression and Anxiety market estimates and forecasts, 2021 - 2033
Fig. 40 Arthritis market estimates and forecasts, 2021 - 2033
Fig. 41 Diabetes market estimates and forecasts, 2021 - 2033
Fig. 42 Glaucoma market estimates and forecasts, 2021 - 2033
Fig. 43 Migraines market estimates and forecasts, 2021 - 2033
Fig. 44 Epilepsy market estimates and forecasts, 2021 - 2033
Fig. 45 Multiple Sclerosis market estimates and forecasts, 2021 - 2033
Fig. 46 AIDS market estimates and forecasts, 2021 - 2033
Fig. 47 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2021 - 2033
Fig. 48 Alzheimers's market estimates and forecasts, 2021 - 2033
Fig. 49 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2021 - 2033
Fig. 50 Parkinson's market estimates and forecasts, 2021 - 2033
Fig. 51 Tourettes market estimates and forecasts, 2021 - 2033
Fig. 52 Others market estimates and forecasts, 2021 - 2033
Fig. 53 Recreational use market estimates and forecasts, 2021 - 2033
Fig. 54 Industrial use market estimates and forecasts, 2021 - 2033
Fig. 55 Key company categorization
Fig. 56 Heat map analysis, 2025
